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Renal oncocytomas reveal a considerable (cyto)genetic 
heterogeneity. A t least 2 genetic subsets are currently recog­
nized, characterized by ( I )  translocations involving break­
point 11 q 13 and (2) the combined loss of chromosomes I and 
X/Y. W e present a case of oncocytoma revealing a 3-way 
translocation involving breakpoint I Iql3,  a der ( I) t ( I;8 )  and 
an add(l9). The der(l) resulted in loss of chromosome I 
sequences. Using fluorescence in situ hybridization, the I I q 13 
breakpoint of the present case proved to be slightly different 
from the one observed previously in 3 cases of renal oncocy­
toma. W hether the 11 q 13 breakpoint observed in our case 
resides in or near another gene remains to be elucidated. Int. 
J. Cancer 73:521-524, 1997.
© 1997 Wiley-Liss, Inc.
Renal oncocytoma is a distinct subtype of renal cell cancer 
(RCC) comprising approximately 4% of cases, in which the male to 
female ratio is 2.5:1. It is an essentially benign neoplasm; clinically, 
most of these tumors are discovered incidentally (Weiss et a l ,  
1995). However, malignant renal oncocytomas have been de­
scribed, indicating that at least some of these neoplasms may have 
malignant potential (Jockle et al, 1987; Psihramis et a l ,  1988; 
Weiss et a l ,  1995). Histologically, renal oncocytomas consist of 
enlarged cells with small, centrally located nuclei, A prominent 
feature of renal oncocytic cells is the accumulation of enlarged 
mitochondria in the cytoplasm. Specific changes in the mitochon­
drial DNA of renal oncocytoma have been observed (Welter et a l ., 
1989; Kovacs, 1993). The frequent finding of telomeric associa­
tions, reflecting a specific type of chromosome instability, is 
another characteristic property (Holzmann et al., 1993).
Cytogenetic analysis of renal oncocytomas has revealed a 
variety of chromosomal patterns, suggesting the existence of 
distinct subsets (Psihramis e t a l , 1988; Crotty et at., 1992; Dobin et 
al,  1992; Meloni et a l,  1992; Kovacs, 1993; van den Berg et a l ,  
1995; Dal Cin et a l ,  1996). At least 2 genetically defined subsets 
appear to emerge, characterized by ( 1) the combined loss of 
chromosomes 1 and X/Y and (2) translocations involving chromo­
some 11 with breakpoint l lq l3 . Sinke et a l  (1997) mapped this 
oncocytoma-specific 11q 13 breakpoint in 2 t(5;ll)-positive renal 
oncocytomas between D11S443/D11S146 and the B C L1 locus. 
The 11 q 13 breakpoint of a third case revealing a t(9; 11 )(p23;q 13) 
has been found to be located within the same region (data not 
shown), suggesting that in the t(5; 11)*- and the t(9;l 1 )-positive renal 
oncocytomas, the same gene at chromosome 11 may be involved in 
the development of these neoplasms. The remaining cases of 
oncocytoma display mixed populations of cells with normal and 
abnormal karyotypes, which fail to show any cytogenetic similarity 
(Kovacs, 1993).
Because little is known about the genetic changes responsible for 
the development of renal oncocytomas, additional studies concern­
ing the genetic constitution of these neoplasms are mandatory. 
Furthermore, the cases of renal oncocytoma with malignant 
potential might reveal genetic changes distinct from those showing 
benign behavior. In these cases, the genetic constitution may prove 
to be a valuable diagnostic and prognostic tool. ITence, we analyzed 
a case of renal oncocytoma using cytogenetic techniques and 
fluorescence in situ hybridization (FISH) and compared the ob­
served findings with data published by others. In addition, we
aimed to find a relation between the biologic behavior of renal 
oncocytomas and their genetic profile. In this light, we comment on 
a possible, genetically defined distinction among real oncocytomas, 
chromophobe adenomas and chromophobe carcinomas.
C A SE HISTORY
A 63-year-old man presented with a solid renal mass. Tumor 
nephrectomy revealed a sharply demarcated tumor nodule measur­
ing 5 X 5 X 4.5 cm with extension into the hilar fatty tissue. On cut 
surface the tumor was light brown. Microscopic examination of 9 
slides showed large, eosinophilic, granular tumor cells with 
increase of double nuclei and focal, extremely pleomorphic nuclei 
arranged in a mostly solid acinar and partially tubulocystic 
architecture. Hale’s staining was performed and revealed neither a 
typical oncytic nor chromophobic staining pattern; only a few 
slightly positive signals were seen in a few cells. No ultrastructural 
studies were performed. No peri-tumoral fibrous pseudocapsule 
was observed, and no lymphocytic infiltration was seen. The tumor 
was diagnosed as a renal oncocytoma (Fig. I).
MATERIALS A N D  M ETHODS
Fresh representative samples of the tumor and adjacent non­
tumor renal tissue were submitted for cytogenetic investigation. 
Cultures were maintained for 13 days in RPMI 1640 supplemented 
with PCS (16%), glutamine and antibiotics. The cultures were 
harvested and chromosome preparations were made according to 
standard cytogenetic techniques. The chromosomes were G- 
banded using pancreatin, and karyotypes were described according 
to the ISCN (1995) guidelines for cancer cytogenetics,
For FISH studies, specific libraries for chromosomes 5, 11 and 
12 (Oncor, Malvern, PA) were used. To identify chromosome 5, a 
hybridization with CEPH YAC 933A7 was performed. Identifica­
tion of chromosome 12 was done using probe paH 8 . For labeling 
of the YAC and pod2H8, the Bio-Nick Labeling System (GIBCO 
BRL, Gaithersburg, MD) was used. In situ hybridization was 
carried out essentially according to the manufacturer’s protocol
(Fig. 3). Cosmids C cIll-4 4  (D11S443), B C ll-c l9  and Cell 1-59 
(D11S146) were used to further define the breakpoint at l lq l3 .  
These experiments were performed as described previously (Sinke 
et a l ,  1997). Cosmid cCLGW454 (D11S688) located at l l q l5  
served to identify chromosome 1L
RESULTS
Cytogenetic and FISH analyses of the present case resulted in 
a 46,XY,der(l)t( 1 ;8)(q43;q 11.1 ),t(5; 11; 12)(q22;p 12;q l 3q24). 
ish(wcp5 +  ,933A7 + , w cpl 1+ ,w c p l2  +  ;wcpl 1+, D11S688 +  , 
D11S443 +  ,D1 lS 1 4 6 + ,B C llc l9 + ;  w cp5+ ,w cp i2+ pal2H 8H -),
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add( 19)(pl3)[cpl0] chromosomal pattern. A karyotype of one of 
the metaphases is given in Figure 2. FISH results defining the 
3-way translocation are shown in Figure 3. Cytogenetic analysis of
10 cells of the non-tumor kidney tissue revealed clonal loss of the Y 
chromosome.
DISCUSSION
Translocations involving chromosome 11 at 11 q 13 are a recur­
rent finding in a subset of renal oncocytoma [see for review 
Neuhaus et a l ,  1997]. In these tumors, chromosome 11 is 
specifically translocated to either chromosome 5 or 9. The genes
F igure 1 -  Histology of the present oncocytom a (H&E).
involved in the oncocytoma-specific 1 I q l3 translocations are not 
known, but the 11 q 13 breakpoint has been mapped between 
D11S443/D1 IS 146 and the BCL1 locus (S in k e r  a l ,  1997).
Cytogenetic analysis and FISH of the present case revealed an 
apparently balanced translocation between chromosomes 5, 11 and
12 in all cells examined. The breakpoint at chromosome 5 clearly 
differed from that observed in the t(5;l l)-positive oncocytomas 
published thus far. Surprisingly, the breakpoint at chromosome
1 l q l 3, which appeared to be similar at a cytogenetic level, proved 
to be (slightly) different using FISH. Cosmid BCLI-cl9, found to 
be located distal to the 11 q 13 breakpoint in the t(5;ll)- and 
t(9 ;l l)-positive oncocytomas, was located proximal to the l l q l 3 
breakpoint of the present case. Whether the latter breakpoint 
resides in or near another gene remains to be elucidated.
Both the der(I )t( 1 ;8)(q43;q11.1) and the add( 19)(q 13) were 
present in 4 of 10 cells analyzed. The der(l) resulted in a loss of a 
small segment o f chromosome 1 and a gain of almost the whole 8q 
arm. Loss of chromosome 1 sequences has been described in renal 
oncocytomas (Psihramis e ta l ,  1988; Crotty et a l ,  1992; Meloni et 
al,  1992; Brown et a l,  1996; Thrash-Bingham et al, 1996). 
Usually, the whole chromosome 1 is missing in these cases, but loss 
of lp appears particularly important (Thrash-Bingham etal., 1996). 
In most cases, loss of chromosome 1 sequences occurs concur­
rently with loss of the X or Y chromosome. In the present case, 
retention of the Y chromosome was observed and loss of chromo­
some 1 sequences involved the region lq43-qter, not lp. Gain of 
chromosome 8 has not been associated with renal oncocytomas 
thus far. An add(19)(ql3) has been described in one of the cases of 
oncocytoma published by van den berg et a l  (1995). In this case, 
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F igure 2 -  A representative karyotype of the present case. Karyotype description is given in the text.
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F ig u re  3 -  FISH on metaphase spreads of the present case using (a) a paint for chromosome 11 (arrows) in conjunction with YAC 933 A7 
(arrowheads), (h) a paint for chromosome 12 (arrows) in conjunction with YAC 933A7 (arrowheads) and (c) a paint for chromosome 5 (arrows) in 
conjunction with pa!2H8 (arrowheads) defining the 3-way translocation among chromosomes 5, 11 and 12.
the latter showed breakpoints different from the t(9; 11) reported in 
other renal oncocytomas.
Although malignant oncocytomas can in principle not exist 
(Eble, 1997) if the diagnosis is made properly, some cases have 
been described in the past (Jockle et aL, 1987; Psihramis e t  a l , 
1988; Weiss et a l 1995). When comparing renal oncocytomas 
with other malignant RCC subtypes, morphological and immuno- 
histochemical data point to a close relationship between renal 
oncocytoma and chromophobe renal cell carcinomas (Stftrkel e t a l ,  
1988, 1989; Noguchi et a l , 1995; Renshaw e t  a l., 1996). Both 
tumor types find their origin in the intercalated cells of the 
collecting tubules and express carbonic anhydrase C. The findings 
of telomere shortening, telomeric associations and mitochondrial 
DNA changes are other common features (Welter e t a l , 1989; 
Kovacs e t a l ,  1992; Holzmann e t  al„  1993; Kovacs, 1993). 
Comparison of the genetic profile of both RCC subtypes reveals 
that a subset of oncocytoma and chromophobe renal cell carcino­
mas consistently show loss of chromosomes 1 and X/Y (Kovacs 
and Kovacs, 1992; Schwerdtle e t a l ,  1996; Shuin e t al., 1996). In 
addition, chromophobe carcinomas reveal loss of chromosomes 2 ,
6 , 10, 13, 17 and 21. These findings present the possibility o f a 
genetic model for an adenoma/carcinoma sequence for chromopho­
bic tumors by postulating that a subgroup of oncocytomas charac­
terized by -1,-Y in a strict sense should be called chromophobic 
adenomas. Subsequent loss of chromosomes 2, 6 , 10, 13, 17 and 21 
might result in progression toward a carcinoma stage, explaining 
the malignant potential occasionally observed in renal oncocytoma. 
Evidence substantiating such a proposed oncogenetic pathway
includes the following: 1) the finding of an oncocytoma containing 
chromophobe cell nests (Noguchi e t  al., 1995)» pointing to a 
possible transition between the two tumor types, 2) cytogenetic 
analysis of a case of oncocytoma revealing multiple chromosome 
losses among chromosomes 1, 2, 6 , 17*21 and Y (Gregori-Romero 
e t  a l . , 1997) and 3) loss of heterozygosity studies showing loss of 
chromosome regions lp, 2pq, 13q, 17pq and Xpq in one case of 
oncocytoma and loss of lpq, 14q and 21q in another (Thrash-
13 ingham e t a l ,  1996). Clinical follow-up is mandatory to draw 
conclusions concerning the above proposed oncogenetic pathway 
but has been seldom published in combination with cytogenetic 
results. The only case of malignant oncocytoma for which cytoge­
netic data have been provided revealed a 44,X,-Y,~I chromosomal 
pattern (Psihramis e t al., 1988), which is in agreement with the 
proposed malignant potential of tumors exhibiting loss o f chromo­
somes 1 and X/Y Clinical follow-up has not been provided for the 
cases with 11 q 13 translocations published thus far, but the 2 
patients with t(5;l l)-positive oncocytomas published by van den 
Berg e t  al. (1995) are currently alive without evidence of disease 
after46 and 96 months, respectively. In addition, to our knowledge, 
no (5;11) or (9;11) translocations have been described in chromo­
phobe carcinomas or in other RCC subtypes.
Therefore, oncocytomas showing translocations involving 1 lq  13, 
may be “ true” oncocytomas, behaving invariably benign. Whether 
our case belongs to the group of “ true '’ oncocytomas must await 
the identification of the gene(s) responsible for the development of 
these neoplasms.
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